Preparation of a stable amiodarone hydrochloride formulation using various nanotechnology methods and pharmaceutical studies
By: Xinyu You, Xianghua Gao, Bingbing Wu, Rongqiang Li, Luoting Yu and Qijie Xu
References
- Gelman, I., Sharma, N., Mckeeman, O., Lee, P., Campagna, N., Tomei, N., et al., The ion channel basis of pharmacological effects of amiodarone on myocardial electrophysiological properties: a comprehensive review, Biomed. Pharmacother., 2024; 174: 116513. 10.1016/j.biopha.2024.116513
- Nie, Y., He, Y., Han, D., Liu, Y., Li, X., Amiodarone inhibits arrhythmias in hypertensive rats by improving myocardial biomechanical Properties, Sci. Rep., 2020; 10(1): 21656. 10.1038/s41598-020-78677-5
- Khaleseh, F., Barzegar-Jalali, M., Zakeri-Milani, P., Karami, Z., Zanjani, M.R.S., Valizadeh, H., How do lipid-based drug delivery systems affect the pharmacokinetic and tissue distribution of amiodarone? A comparative study of liposomes, solid lipid nanoparticles, and nanoemulsions, Iran. J. Basic Med. Sci., 2024; 27(7): 857–867. 10.22038/IJBMS.2024.75152.16292
- Krajcar, D., Grabnar, I., Jereb, R. Legen, L., Opara, J., Predictive potential of BCS and pharmacokinetic parameters on study outcome: analysis of 198 in vivo bioequivalence studiesm, Eur. J. Drug. Metab. Pharmacokinet., 2023; 48(3): 241–255. 10.1007/s13318-023-00821-z
- Motawea, A., Ahmed, D.A.M., El-Mansy, A.A., Saleh, N.M., Crucial role of PLGA nanoparticles in mitigating the amiodarone-induced pulmonary toxicity, Int. J. Nanomed., 2021; 16: 4713–4737. 10.2147/IJN.S314074
- Awan, A.M., Farid, A., Shah, S.U., Khan, D., Khan, D., Rehman, F.U., Dar, M.J., et al., Nanocrytals-mediated oral drug delivery: Enhanced bioavailability of amiodarone, Pharmaceutics, 2022; 14(6): 1300. 10.3390/pharmaceutics14061300
- Ahmed, M.S., Rodell, C.B., Hulsmans, M., Kohler, R.H., Aguirre, A.D., Nahrendorf, M., et al., A supramolecular nanocarrier for delivery of amiodarone anti-arrhythmic therapy to the heart, Bioconjug. Chem., 2019; 30(3): 733–740. 10.1021/acs.bioconjchem.8b00882
- Zhuge, Y., Zheng, Z.F., Xie, M.Q., Li, L., Wang, F., Gao, F., Preparation of liposomal amiodarone and investigation of its cardiomyocyte-targeting ability in cardiac radiofrequency ablation rat model, Int. J. Nanomed., 2016; 11: 2359–2367. 10.2147/IJN.S98815
- Chen, J., Tamareille, S., Chèvremont, E., Gimel, J.C., Calvignac, B., Dallerac, D., et al., Distribution of amiodarone between lipid nanocapsules and residual micelles: Tangential flow filtration as a purification method and its impact on cytotoxicity, Int. J. Pharm., 2025; 677: 125651. 10.1016/j. ijpharm.2025.125651
- Creteanu, A., Lisa, G., Vasile, C., Popescu, M.C., Spac, A.F., Tantaru, G., Development of solid lipid nanoparticles for controlled amiodarone delivery, Methods. Protoc., 2023; 6(5): 97. 10.3390/mps6050097
- Oliveira, N.K., Frank, L.A., Squizani, E.D., Reuwsaat, J.C.V., Marques, B.M., Motta, H., et al., New nanotechnological formulation based on amiodarone-loaded lipid core nanocapsules displays anticryptococcal effect, Eur. J. Pharm. Sci., 2021; 162: 105816. 10.1016/j.ejps.2021.105816
- Saorin, A., Saorin, G., Duzagac, F., Parisse, P., Cao, N., CoRona, G., et al., Microfluidic production of amiodarone loaded nanoparticles and application in drug repositioning in ovarian cancer, Sci. Rep., 2024; 14(1): 6280. 10.1038/s41598-024-55801-3
- Abdollahi, S., Raissi, H., Farzad, F., Examine stability polyvinyl alcohol-stabilized nanosuspensions to overcome the challenge of poor drug solubility utilizing molecular dy-namic simulation, Sci. Rep., 2024; 14: 17386. 10.1038/s41598-024-68362-2
- Creteanu, A., Lisa, G., Vasile, C., Popescu, M.C., Spac, A.F., Tantaru, G., Development of solid lipid nanoparticles for controlled amiodarone delivery, Methods Protoc., 2023; 6(5), 97. 10.3390/mps6050097
- FDA, Guidance for industry: Excipient safety for oral drug products. U.S. Food and Drug Administration, 2022. https://www.fda.gov/media/156410/download
- Khan, K.U., Minhas, M.U., Badshah, S.F., Suhail, M., Ahmad, A., Igaz, S., Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs, Life. Sci., 2022; 291: 120301. 10.1016/j.lfs.2022.120301
- Bonhoeffer, B., Kordikowski, A., John, E., Juhake, M., Numerical modeling of the dissolution of drug nanocrystals and its application to industrial product development, ADMET DMPK, 2022; 10(4), 253–287. 10.5599/admet.1437
- Pinar, S.G., Oktay, A.N., Karakucuk, A.E., Celebi, N., Formulation strategies of nanosuspensions for various administration routes, Pharmaceutics, 2023; 15(5): 1520. 10.3390/pharmaceutics15051520
- Jacob, S., Kather, F.S., Boddu, S.H.S., Attimarad, M.A., Nair, A.B., Nanosuspension innovations: Expanding horizons in drug delivery techniques, Pharmaceutics, 2025; 17(1): 136. 10.3390/pharmaceutics17010136
- Chavhan, R., Nanosuspensions: Enhancing drug bioavailability through nanonization, Ann. Pharm. Fr., 2025; 83(2): 251–271. 10.1016/j.pharma.2024.06.003
- Tsuzuki, T., Mechanochemical synthesis of metal oxide nanoparticles, Commun. Chem., 2021; 4(1): 143. 10.1038/s42004-021-00582-3
- Tehrani, A.A., Omranpoor, M.M., Vatanara, A., Seyedabadi, M., Ramezani, V., Formation of nanosuspensions in bottom-up approach: Theories and optimization, DARU J. Pharm. Sci., 2019; 27(1): 451–473. 10.1007/s40199-018-00235-2
- Touqeer, S.I., Jahan, N., Abbas, N., Ali, A., Formulation and process optimization of rauvolfia serpentina nanosuspension by HPMC and in vitro evaluation of ACE inhibitory potential, J. Funct. Biomater., 2022; 13(4): 268. 10.3390/jfb13040268
- Bischoff, K., Esen, C., Hellmann, R., Preparation of dispersed copper(II) oxide nanosus-pensions as precursor for femtosecond reductive laser sintering by high-energy ball milling, Nanomaterials, 2023; 13(19): 2693. 10.3390/nano13192693
- Afolabi, A., Akinlabi, O., Bilgili, E., Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view, Eur. J. Pharm. Sci., 2014; 51: 75–86. 10.1016/j.ejps. 2013.09.002
- Li, F., Li, L., Wang, S., Yang, Y., Li, J., Liu, D., et al., Improved dissolution and oral absorption by co-grinding active drug probucol and ternary stabilizers mixtures with planetary beads-milling method, Asian. J. Pharm. Sci., 2019; 14(6): 69–657. 10.1016/j.ajps.2018.12.001
- Awan, A.M., Farid, A., Shah, S.U., Khan, D., Reman, F.U., Dar, M.J., et al., Nanocrytals-mediated oral drug delivery: enhanced bioavailability of amiodarone, Pharmaceutics, 2022; 14(6), 1300. 10.3390/pharmaceutics14061300
- Morita, T., Torii, Y., Imamura, H., Kadota, T., Sakuma, F., Higashi, K., et al., Pair potential between poloxamer 407 micelles in 14 wt % aqueous solution clarifying the sol-gel-sol transition by temperature rise, J. Phys. Chem. Lett., 2024; 15(31), 7909–7915. 10.1021/acs.jpclett.4c01138
- Souney, P.F., Cooper, W.D., Cushing, D.J., PM101: Intravenous amiodarone formulation changes can improve medication safety. Expert Opin. Drug. Saf., 2010; 9(2), 319–333. 10.1517/14740331003586811
- Personal Care Products Council, 1-23-2013. Concentration of use by FDA product category: PVP. 3 pages
- Personal Care Products Council, 5-22-2013. Concentration of use by product category: Updated information on PVP. 1 page
- FDA Inactive Ingredient Guide (IIG), https://www.fda.gov/drugs/inactive-ingredient-search-fda-approved-drug-products?spm=5176.28103460.0.0.121f7551Kgq1GZ
Language: English
Page range: 88 - 101
Submitted on: Jul 24, 2025
Accepted on: May 11, 2026
Published on: Jun 12, 2026
Published by: West Pomeranian University of Technology, Szczecin
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Keywords:
Related subjects:
© 2026 Xinyu You, Xianghua Gao, Bingbing Wu, Rongqiang Li, Luoting Yu, Qijie Xu, published by West Pomeranian University of Technology, Szczecin
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.